X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 65 filers reported holding X4 PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,397,041 | -43.8% | 15,960,588 | 0.0% | 1.94% | -39.0% |
| Q2 2023 | $30,963,541 | +291568.6% | 15,960,588 | +30.8% | 3.19% | +140.3% |
| Q1 2023 | $10,616 | -12.4% | 12,202,510 | 0.0% | 1.33% | -2.0% |
| Q4 2022 | $12,117 | -99.9% | 12,202,510 | +91.0% | 1.35% | +3.8% |
| Q3 2022 | $10,926,000 | +274.9% | 6,389,436 | +111.6% | 1.30% | +281.3% |
| Q2 2022 | $2,914,000 | -44.9% | 3,019,540 | 0.0% | 0.34% | -33.3% |
| Q1 2022 | $5,284,000 | -20.1% | 3,019,540 | +4.6% | 0.51% | -2.1% |
| Q4 2021 | $6,610,000 | -41.0% | 2,886,542 | +36.2% | 0.52% | -24.7% |
| Q3 2021 | $11,212,000 | -18.6% | 2,119,540 | 0.0% | 0.70% | -22.9% |
| Q2 2021 | $13,777,000 | -24.5% | 2,119,540 | 0.0% | 0.90% | -12.7% |
| Q1 2021 | $18,249,000 | +72.2% | 2,119,540 | +28.6% | 1.03% | +55.5% |
| Q4 2020 | $10,600,000 | -5.0% | 1,648,485 | 0.0% | 0.66% | -36.1% |
| Q3 2020 | $11,160,000 | -27.4% | 1,648,485 | 0.0% | 1.04% | -35.4% |
| Q2 2020 | $15,364,000 | -6.8% | 1,648,485 | 0.0% | 1.61% | -42.3% |
| Q1 2020 | $16,485,000 | -6.5% | 1,648,485 | 0.0% | 2.79% | +6.0% |
| Q4 2019 | $17,639,000 | – | 1,648,485 | – | 2.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
| Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
| NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
| Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
| Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
| Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
| Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |